Serotonin 5-HT2B receptors are required for bone-marrow contribution to pulmonary arterial hypertension
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Serotonin 5-HT2B receptors are required for bone-marrow contribution to pulmonary arterial hypertension
Authors
Keywords
-
Journal
BLOOD
Volume 119, Issue 7, Pages 1772-1780
Publisher
American Society of Hematology
Online
2011-12-21
DOI
10.1182/blood-2011-06-358374
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- C-Kit–Positive Cells Accumulate in Remodeled Vessels of Idiopathic Pulmonary Arterial Hypertension
- (2011) David Montani et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Bad blood, bad endothelium: ill fate?
- (2011) M. Yoder et al. BLOOD
- Hypoxia-inducible factors in human pulmonary arterial hypertension: a link to the intrinsic myeloid abnormalities
- (2011) S. Farha et al. BLOOD
- C-122, a novel antagonist of serotonin receptor 5-HT2B, prevents monocrotaline-induced pulmonary arterial hypertension in rats
- (2011) David A. Zopf et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Ineffective erythropoiesis with reduced red blood cell survival in serotonin-deficient mice
- (2011) Pascal Amireault et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Imatinib in Pulmonary Arterial Hypertension Patients with Inadequate Response to Established Therapy
- (2010) Hossein A. Ghofrani et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Basic Science of Pulmonary Arterial Hypertension for Clinicians
- (2010) Stephen L. Archer et al. CIRCULATION
- Terguride ameliorates monocrotaline-induced pulmonary hypertension in rats
- (2010) R. Dumitrascu et al. EUROPEAN RESPIRATORY JOURNAL
- Targeting of c-kit+ haematopoietic progenitor cells prevents hypoxic pulmonary hypertension
- (2010) N. Gambaryan et al. EUROPEAN RESPIRATORY JOURNAL
- Imatinib inhibits bone marrow-derived c-kit+ cell mobilisation in hypoxic pulmonary hypertension
- (2010) N. Gambaryan et al. EUROPEAN RESPIRATORY JOURNAL
- PRX-08066, a Novel 5-Hydroxytryptamine Receptor 2B Antagonist, Reduces Monocrotaline-Induced Pulmonary Arterial Hypertension and Right Ventricular Hypertrophy in Rats
- (2010) S. L. Porvasnik et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Endothelial Progenitor Cells in Pulmonary Arterial Hypertension
- (2010) Gerhard-Paul Diller et al. TRENDS IN CARDIOVASCULAR MEDICINE
- The granulocyte-macrophage colony-stimulating factor receptor: linking its structure to cell signaling and its role in disease
- (2009) T. R. Hercus et al. BLOOD
- Parallel Functional Activity Profiling Reveals Valvulopathogens Are Potent 5-Hydroxytryptamine2B Receptor Agonists: Implications for Drug Safety Assessment
- (2009) X.-P. Huang et al. MOLECULAR PHARMACOLOGY
- Circulating Angiogenic Precursors in Idiopathic Pulmonary Arterial Hypertension
- (2008) Kewal Asosingh et al. AMERICAN JOURNAL OF PATHOLOGY
- Fenfluramine: riddle or Rosetta stone?
- (2008) E. K. Weir et al. EUROPEAN RESPIRATORY JOURNAL
- Sustained Endothelial Progenitor Cell Dysfunction After Chronic Hypoxia-Induced Pulmonary Hypertension
- (2008) Glenn Marsboom et al. STEM CELLS
- Bone marrow progenitor cells contribute to repair and remodeling of the lung and heart in a rat model of progressive pulmonary hypertension
- (2007) Jeffrey L. Spees et al. FASEB JOURNAL
- Activation of c-kit is necessary for mobilization of reparative bone marrow progenitor cells in response to cardiac injury
- (2007) Shafie S. Fazel et al. FASEB JOURNAL
- Pathogenic mechanisms of pulmonary arterial hypertension
- (2007) Stephen Y. Chan et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation